MediWound Ltd.

Good day, and thank you for standing by. Welcome to MediWOON fourth quarter and year-end 2021 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question and answer session. To ask a question during the session, you'll need to press star one on your telephone. Please be advised that today's conference is being recorded. If you require any further assistance, please press star zero. I would now like to hand the conference over to Monique Coffey with LifeSci Advisors. Please go ahead.

Thank you, Operator, and good morning, everyone. Earlier today, MediWound issued a press release announcing financial results for the fourth quarter and year ended December 31, 2021. You may access that release on the company's website under the Investors tab. With us today are Sharon Malka, Chief Executive Officer of MediWound, and Boaz Gurlavi, Chief Financial Officer. Following management's prepared remarks, we will open the call for Q&A. Before we begin, I would like to remind everyone that statements made during the call, including the Q&A session relating to Meadowoom's expected future performance, future business prospects, or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. Although the company believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual outcomes and results are subject to risks and uncertainties that could differ materially from those forecasts due to the impact of many factors beyond the control of MetaWound. The company assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events, or otherwise. Participants are directed to the cautionary notes set forth in today's press release, as well as the risk factors set forth in Metawound's annual report filed with the SEC for factors that could cause actual results to differ materially from those anticipated in the forward-looking statements. The conference call is a property of Metawound, and any recording or rebroadcast is expressly prohibited without the written consent of Metawound. Now I'd like to turn the call over to Sharon Malka, Chief Executive Officer of MediWin. Sharon?

Sharon?